Fluticasone Propionate MDPI (multidose dry powder inhaler)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluticasone Propionate MDPI (multidose dry powder inhaler), covering 2017-04-14 to 2017-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma [Phase 3]